Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer
Abstract Recurrent gene mutations and fusions in cancer patients are likely to be associated with cancer progression or recurrence by Vogelstein et al. (Science (80-) 340, 1546–1558 (2013)). In this study, we investigated gene mutations and fusions that recurrently occurred in early-stage cancer pat...
Guardado en:
Autores principales: | Su Han Cho, Shinkyo Yoon, Dae Ho Lee, Sang-We Kim, Kwoneel Kim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5ab5642c5e294704bbfa5c03faf4b75f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association of perioperative serum carcinoembryonic antigen level and recurrence in low-risk stage IIA colon cancer.
por: Han-Gil Kim, et al.
Publicado: (2021) -
Predictive Risk Factors for Early Recurrence of Stage pIIIA-N2 Non-Small Cell Lung Cancer
por: Yu Q, et al.
Publicado: (2021) -
Novel gene signatures for stage classification of the squamous cell carcinoma of the lung
por: Angel Juarez-Flores, et al.
Publicado: (2021) -
Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes
por: Si-Yang Liu, et al.
Publicado: (2021) -
A highly expressed mRNA signature for predicting survival in patients with stage I/II non-small-cell lung cancer after operation
por: Nan Ma, et al.
Publicado: (2021)